{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T04:27:48Z","timestamp":1782793668841,"version":"3.54.5"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100019033","name":"Key Research and Development Program of Liaoning Province","doi-asserted-by":"publisher","award":["2023JH2\/101700184"],"award-info":[{"award-number":["2023JH2\/101700184"]}],"id":[{"id":"10.13039\/501100019033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019033","name":"Key Research and Development Program of Liaoning Province","doi-asserted-by":"publisher","award":["2023JH2\/20200003"],"award-info":[{"award-number":["2023JH2\/20200003"]}],"id":[{"id":"10.13039\/501100019033","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neoplasia"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.neo.2026.101285","type":"journal-article","created":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T01:29:47Z","timestamp":1770859787000},"page":"101285","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["OTUD4 regulates pancreatic cancer progression via Hippo\/YAP axis"],"prefix":"10.1016","volume":"73","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-5005-5453","authenticated-orcid":false,"given":"Shuaike","family":"Qu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beibei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongbo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingwen","family":"Gai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaguang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3596-4339","authenticated-orcid":false,"given":"Jian","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.neo.2026.101285_bib0001","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"4","key":"10.1016\/j.neo.2026.101285_bib0002","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.7150\/thno.53438","article-title":"YAP in pancreatic cancer: oncogenic role and therapeutic strategy","volume":"11","author":"Mao","year":"2021","journal-title":"Theranostics."},{"key":"10.1016\/j.neo.2026.101285_bib0003","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1146\/annurev-biochem-013118-111829","article-title":"The Hippo pathway: biology and pathophysiology","volume":"88","author":"Ma","year":"2019","journal-title":"Annu. Rev. Biochem."},{"issue":"12","key":"10.1016\/j.neo.2026.101285_bib0004","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1038\/sj.onc.1208445","article-title":"The Ste20-like kinase Mst2 activates the human large tumor suppressor kinase Lats1","volume":"24","author":"Chan","year":"2005","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.neo.2026.101285_bib0005","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.cell.2005.06.007","article-title":"The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila Homolog of YAP","volume":"122","author":"Huang","year":"2005","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.neo.2026.101285_bib0006","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1101\/gad.1843810","article-title":"A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF(beta-TRCP)","volume":"24","author":"Zhao","year":"2010","journal-title":"Genes Dev."},{"issue":"48","key":"10.1016\/j.neo.2026.101285_bib0007","doi-asserted-by":"crossref","first-page":"37159","DOI":"10.1074\/jbc.M110.152942","article-title":"The hippo tumor pathway promotes TAZ degradation by phosphorylating a phosphodegron and recruiting the SCF{beta}-TrCP E3 ligase","volume":"285","author":"Liu","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.neo.2026.101285_bib0008","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.fertnstert.2020.07.031","article-title":"Hippo signaling disruption and ovarian follicle activation in infertile patients","volume":"114","author":"Hsueh","year":"2020","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.neo.2026.101285_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217864","article-title":"Nuclear localization of YAP in pancreatic cancer: more players besides Hippo pathway","volume":"629","author":"Xie","year":"2025","journal-title":"Cancer Lett."},{"issue":"2","key":"10.1016\/j.neo.2026.101285_bib0010","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.cmet.2018.07.010","article-title":"Interplay between YAP\/TAZ and metabolism","volume":"28","author":"Koo","year":"2018","journal-title":"Cell Metab."},{"issue":"10","key":"10.1016\/j.neo.2026.101285_bib0011","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1101\/gad.888601","article-title":"TEAD\/TEF transcription factors utilize the activation domain of YAP65, a Src\/yes-associated protein localized in the cytoplasm","volume":"15","author":"Vassilev","year":"2001","journal-title":"Genes Dev."},{"issue":"21","key":"10.1016\/j.neo.2026.101285_bib0012","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1101\/gad.1602907","article-title":"Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control","volume":"21","author":"Zhao","year":"2007","journal-title":"Genes Dev."},{"issue":"9","key":"10.1016\/j.neo.2026.101285_bib0013","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1136\/gutjnl-2022-327492","article-title":"SDCBP promotes pancreatic cancer progression by preventing YAP1 from \u03b2-TrCP-mediated proteasomal degradation","volume":"72","author":"Liu","year":"2023","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.neo.2026.101285_bib0014","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/s41419-025-07746-2","article-title":"VCPIP1 facilitates pancreatic adenocarcinoma progression via Hippo\/YAP signaling","volume":"16","author":"Liu","year":"2025","journal-title":"Cell Death. Dis."},{"issue":"6","key":"10.1016\/j.neo.2026.101285_bib0015","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/s43018-023-00577-0","article-title":"An allosteric pan-TEAD inhibitor blocks oncogenic YAP\/TAZ signaling and overcomes KRAS G12C inhibitor resistance","volume":"4","author":"Hagenbeek","year":"2023","journal-title":"Nat. Cancer"},{"issue":"24","key":"10.1016\/j.neo.2026.101285_bib0016","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.178535","article-title":"YAP\/TAZ mediates resistance to KRAS inhibitors through inhibiting proapoptosis and activating the SLC7A5\/mTOR axis","volume":"9","author":"Yang","year":"2024","journal-title":"JCI. Insight."},{"issue":"1","key":"10.1016\/j.neo.2026.101285_bib0017","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/s41392-023-01555-9","article-title":"CDK7-YAP-LDHD axis promotes D-lactate elimination and ferroptosis defense to support cancer stem cell-like properties","volume":"8","author":"Lv","year":"2023","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.neo.2026.101285_bib0018","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/s00018-024-05296-y","article-title":"Epigenetic regulation of DNA repair gene program by Hippo\/YAP1-TET1 axis mediates sorafenib resistance in HCC","volume":"81","author":"Mo","year":"2024","journal-title":"Cell Mol. Life Sci."},{"issue":"9","key":"10.1016\/j.neo.2026.101285_bib0019","doi-asserted-by":"crossref","DOI":"10.1172\/JCI155468","article-title":"Combinatorial targeting of Hippo-STRIPAK and PARP elicits synthetic lethality in gastrointestinal cancers","volume":"132","author":"An","year":"2022","journal-title":"J. Clin. Invest."},{"issue":"15","key":"10.1016\/j.neo.2026.101285_bib0020","doi-asserted-by":"crossref","first-page":"3208","DOI":"10.1016\/j.cell.2023.05.047","article-title":"QKI shuttles internal m(7)G-modified transcripts into stress granules and modulates mRNA metabolism","volume":"186","author":"Zhao","year":"2023","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.neo.2026.101285_bib0021","doi-asserted-by":"crossref","DOI":"10.15252\/embj.201899506","article-title":"Loss of VGLL4 suppresses tumor PD-L1 expression and immune evasion","volume":"38","author":"Wu","year":"2019","journal-title":"EMBO J."},{"issue":"1","key":"10.1016\/j.neo.2026.101285_bib0022","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41556-021-00813-8","article-title":"The Hippo pathway kinases LATS1 and LATS2 attenuate cellular responses to heavy metals through phosphorylating MTF1","volume":"24","author":"Han","year":"2022","journal-title":"Nat. Cell Biol."},{"issue":"7","key":"10.1016\/j.neo.2026.101285_bib0023","doi-asserted-by":"crossref","first-page":"3817","DOI":"10.1093\/nar\/gkac189","article-title":"Oxidative stress-CBP axis modulates MOB1 acetylation and activates the Hippo signaling pathway","volume":"50","author":"Jin","year":"2022","journal-title":"Nucleic. Acids. Res."},{"issue":"21","key":"10.1016\/j.neo.2026.101285_bib0024","doi-asserted-by":"crossref","first-page":"9443","DOI":"10.7150\/thno.46078","article-title":"Regulation of Hippo\/YAP signaling and Esophageal Squamous Carcinoma progression by an E3 ubiquitin ligase PARK2","volume":"10","author":"Zhou","year":"2020","journal-title":"Theranostics."},{"issue":"1","key":"10.1016\/j.neo.2026.101285_bib0025","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1038\/s41467-021-22987-3","article-title":"YAP promotes the activation of NLRP3 inflammasome via blocking K27-linked polyubiquitination of NLRP3","volume":"12","author":"Wang","year":"2021","journal-title":"Nat. Commun."},{"issue":"35","key":"10.1016\/j.neo.2026.101285_bib0026","article-title":"TRIM65\/NF2\/YAP1 Signaling coordinately orchestrates metabolic and immune advantages in hepatocellular carcinoma","volume":"11","author":"Bian","year":"2024","journal-title":"Adv. Sci. (Weinh)"},{"issue":"1","key":"10.1016\/j.neo.2026.101285_bib0027","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s12964-022-00963-8","article-title":"RBCK1 is an endogenous inhibitor for triple negative breast cancer via hippo\/YAP axis","volume":"20","author":"Li","year":"2022","journal-title":"Cell Commun. Signal.: CCS"},{"issue":"1","key":"10.1016\/j.neo.2026.101285_bib0028","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.molcel.2018.10.030","article-title":"OTUB2 Promotes cancer metastasis via hippo-independent activation of YAP and TAZ","volume":"73","author":"Zhang","year":"2019","journal-title":"Mol. Cell"},{"issue":"12","key":"10.1016\/j.neo.2026.101285_bib0029","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1038\/s41419-022-05474-5","article-title":"USP36 facilitates esophageal squamous carcinoma progression via stabilizing YAP","volume":"13","author":"Zhang","year":"2022","journal-title":"Cell Death. Dis."},{"issue":"1","key":"10.1016\/j.neo.2026.101285_bib0030","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/s12935-023-03078-3","article-title":"Synergistic effect of YOD1 and USP21 on the Hippo signaling pathway","volume":"23","author":"Park","year":"2023","journal-title":"Cancer Cell Int."},{"issue":"1","key":"10.1016\/j.neo.2026.101285_bib0031","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/s41420-024-02136-7","article-title":"Regulation of Hippo\/YAP axis in colon cancer progression by the deubiquitinase JOSD1","volume":"10","author":"Sun","year":"2024","journal-title":"Cell Death. Discov."},{"issue":"1","key":"10.1016\/j.neo.2026.101285_bib0032","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/s13046-022-02410-5","article-title":"DUB1 suppresses hippo signaling by modulating TAZ protein expression in gastric cancer","volume":"41","author":"Wang","year":"2022","journal-title":"J. Experiment. Clinic. Cancer Res.: CR"},{"issue":"4","key":"10.1016\/j.neo.2026.101285_bib0033","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/s41388-023-02905-1","article-title":"PSMD14 stabilizes estrogen signaling and facilitates breast cancer progression via deubiquitinating er\u03b1","volume":"43","author":"Yang","year":"2024","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.neo.2026.101285_bib0034","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.molcel.2018.01.009","article-title":"OTUD4 Is a phospho-activated K63 deubiquitinase that regulates MyD88-dependent signaling","volume":"69","author":"Zhao","year":"2018","journal-title":"Mol. Cell"},{"issue":"2","key":"10.1016\/j.neo.2026.101285_bib0035","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/s41418-022-01107-8","article-title":"N(6)-methyladenosine-modified USP13 induces pro-survival autophagy and imatinib resistance via regulating the stabilization of autophagy-related protein 5 in gastrointestinal stromal tumors","volume":"30","author":"Gao","year":"2023","journal-title":"Cell Death. Differ."},{"issue":"1","key":"10.1016\/j.neo.2026.101285_bib0036","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1186\/s13046-022-02528-6","article-title":"UBR7 inhibits HCC tumorigenesis by targeting Keap1\/Nrf2\/Bach1\/HK2 and glycolysis","volume":"41","author":"Zhao","year":"2022","journal-title":"J. Experiment. Clinic. Cancer Res.: CR"},{"issue":"12","key":"10.1016\/j.neo.2026.101285_bib0037","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1002\/1878-0261.12835","article-title":"Targeting the ubiquitin-proteasome system in a pancreatic cancer subtype with hyperactive MYC","volume":"14","author":"Lankes","year":"2020","journal-title":"Mol. Oncol."},{"issue":"32","key":"10.1016\/j.neo.2026.101285_bib0038","article-title":"Lipid droplet-organized MDM2-mediated P53 degradation: a metabolic switch governing diet-driven tumor progression","volume":"12","author":"Liu","year":"2025","journal-title":"Adv. Sci. (Weinh)"},{"issue":"4","key":"10.1016\/j.neo.2026.101285_bib0039","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1158\/0008-5472.CAN-20-0790","article-title":"MDMX recruits UbcH5c to facilitate MDM2 E3 ligase activity and subsequent p53 degradation In vivo","volume":"81","author":"Yang","year":"2021","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.neo.2026.101285_bib0040","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1158\/2159-8290.CD-22-1131","article-title":"Targeted MDM2 degradation reveals a new vulnerability for p53-inactivated triple-negative breast cancer","volume":"13","author":"Adams","year":"2023","journal-title":"Cancer Discov."},{"issue":"1","key":"10.1016\/j.neo.2026.101285_bib0041","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13046-022-02586-w","article-title":"Helicobacter pylori-induced NAT10 stabilizes MDM2 mRNA via RNA acetylation to facilitate gastric cancer progression","volume":"42","author":"Deng","year":"2023","journal-title":"J. Experiment. Clinic. Cancer Res.: CR"},{"issue":"3","key":"10.1016\/j.neo.2026.101285_bib0042","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/s41419-024-06569-x","article-title":"OTUD4 promotes the progression of glioblastoma by deubiquitinating CDK1 and activating MAPK signaling pathway","volume":"15","author":"Ci","year":"2024","journal-title":"Cell Death. Dis."},{"issue":"5","key":"10.1016\/j.neo.2026.101285_bib0043","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2025.115681","article-title":"OTUD4 inhibits ferroptosis by stabilizing GPX4 and suppressing autophagic degradation to promote tumor progression","volume":"44","author":"Chen","year":"2025","journal-title":"Cell Rep."},{"issue":"50","key":"10.1016\/j.neo.2026.101285_bib0044","doi-asserted-by":"crossref","first-page":"3645","DOI":"10.1038\/s41388-024-03141-x","article-title":"USP10 drives cancer stemness and enables super-competitor signalling in colorectal cancer","volume":"43","author":"Reissland","year":"2024","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.neo.2026.101285_bib0045","doi-asserted-by":"crossref","first-page":"6473","DOI":"10.1038\/s41467-023-42257-8","article-title":"USP36 stabilizes nucleolar Snail1 to promote ribosome biogenesis and cancer cell survival upon ribotoxic stress","volume":"14","author":"Qin","year":"2023","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.neo.2026.101285_bib0046","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1186\/s13046-024-03160-2","article-title":"USP36 promotes tumorigenesis and tamoxifen resistance in breast cancer by deubiquitinating and stabilizing ER\u03b1","volume":"43","author":"Zhuang","year":"2024","journal-title":"J. Experiment. Clinic. Cancer Res.: CR"},{"issue":"5","key":"10.1016\/j.neo.2026.101285_bib0047","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1083\/jcb.200208112","article-title":"VCIP135, a novel essential factor for p97\/p47-mediated membrane fusion, is required for Golgi and ER assembly in vivo","volume":"159","author":"Uchiyama","year":"2002","journal-title":"J. Cell Biol."},{"issue":"1","key":"10.1016\/j.neo.2026.101285_bib0048","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.cell.2013.05.046","article-title":"OTU deubiquitinases reveal mechanisms of linkage specificity and enable ubiquitin chain restriction analysis","volume":"154","author":"Mevissen","year":"2013","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.neo.2026.101285_bib0049","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1013052","article-title":"Disrupting the OTUD4-USP7 deubiquitinase complex to suppress herpesvirus replication: a novel antiviral strategy","volume":"21","author":"Wang","year":"2025","journal-title":"PLoS. Pathog."},{"issue":"1","key":"10.1016\/j.neo.2026.101285_bib0050","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/s41422-018-0107-6","article-title":"Induction of OTUD4 by viral infection promotes antiviral responses through deubiquitinating and stabilizing MAVS","volume":"29","author":"Liuyu","year":"2019","journal-title":"Cell Res."},{"issue":"21","key":"10.1016\/j.neo.2026.101285_bib0051","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1056\/NEJMoa1215993","article-title":"Ataxia, dementia, and hypogonadotropism caused by disordered ubiquitination","volume":"368","author":"Margolin","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.neo.2026.101285_bib0052","doi-asserted-by":"crossref","DOI":"10.1172\/JCI176390","article-title":"Pharmacological suppression of the OTUD4\/CD73 proteolytic axis revives antitumor immunity against immune-suppressive breast cancers","volume":"134","author":"Zhu","year":"2024","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.neo.2026.101285_bib0053","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s12935-019-0816-z","article-title":"OTU deubiquitinase 4 is silenced and radiosensitizes non-small cell lung cancer cells via inhibiting DNA repair","volume":"19","author":"Wu","year":"2019","journal-title":"Cancer Cell Int."},{"issue":"1","key":"10.1016\/j.neo.2026.101285_bib0054","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1186\/s13046-024-03232-3","article-title":"Selective metabolic regulations by p53 mutant variants in pancreatic cancer","volume":"43","author":"Caporali","year":"2024","journal-title":"J. Experiment. Clinic. Cancer Res.: CR"},{"issue":"11","key":"10.1016\/j.neo.2026.101285_bib0055","doi-asserted-by":"crossref","first-page":"eadq4416","DOI":"10.1126\/sciadv.adq4416","article-title":"Targeting the NPY\/NPY1R signaling axis in mutant p53-dependent pancreatic cancer impairs metastasis","volume":"11","author":"Chambers","year":"2025","journal-title":"Sci. Adv."},{"key":"10.1016\/j.neo.2026.101285_bib0056","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1186\/s12935-020-01397-3","article-title":"RNF181 modulates hippo signaling and triple negative breast cancer progression","volume":"20","author":"Zhou","year":"2020","journal-title":"Cancer Cell Int."}],"container-title":["Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147655862600014X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147655862600014X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T06:40:30Z","timestamp":1777617630000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S147655862600014X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":56,"alternative-id":["S147655862600014X"],"URL":"https:\/\/doi.org\/10.1016\/j.neo.2026.101285","relation":{},"ISSN":["1476-5586"],"issn-type":[{"value":"1476-5586","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"OTUD4 regulates pancreatic cancer progression via Hippo\/YAP axis","name":"articletitle","label":"Article Title"},{"value":"Neoplasia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neo.2026.101285","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101285"}}